Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 02 Oct 2026 for Synchrony Financial, €53k. Read the official filing
Filing timeline
BuySaleEllen M. Zane
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Ellen M. Zane: trading record in brief
Ellen M. Zane, listed as senior executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Synchrony Financial, Boston Scientific Corp and Haemonetics Corp. Between 2 February 2016 and 30 September 2026, the trades on record add up to 62 filings.
No open-market purchase appears, only 4 sales worth €3.6M. Outside the open market, there are 57 share grants.
Most recently, on 2 October 2026, the filings show a share grant worth €53k in Synchrony Financial. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ellen M. Zane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
846 shares@ US$70.97Common StockSEC:0001369850-26-000010:0
14 shares@ US$80.750.5% of flowDividend Equivalent UnitSEC:0001369850-26-000009:0
2,538 sharesCommon StockSEC:0000313143-26-000111:0
883 shares@ US$68.0226.7% of flowCommon StockSEC:0001369850-26-000003:0
14 shares@ US$72.310.1% of flowDividend Equivalent UnitSEC:0001369850-26-000002:0
660 shares@ US$83.437.4% of flowCommon StockSEC:0001369850-26-000001:0
15 shares@ US$70.470.1% of flowDividend Equivalent UnitSEC:0001369850-25-000005:0
12,891 shares@ US$98.283930.8% of flowCommon StockSEC:0001225208-25-008997:0
12,891 shares0Common StockSEC:0001225208-25-008842:0
9,990 shares@ US$101.131224.3% of flowCommon StockSEC:0001225208-25-008761:0
2,901 shares@ US$102.24027.1% of flowCommon StockSEC:0001225208-25-008761:1
775 shares@ US$71.057.4% of flowCommon StockSEC:0001369850-25-000003:0
15 shares@ US$71.490.1% of flowDividend Equivalent UnitSEC:0001369850-25-000002:0
2,693 sharesCommon StockSEC:0001127602-25-019599:0
825 shares@ US$66.747.4% of flowCommon StockSEC:0001601712-25-000223:0
17 shares@ US$60.490.1% of flowDividend Equivalent UnitSEC:0001601712-25-000190:0
2,081 shares0Common StockSEC:0001225208-25-004936:0
1,039 shares@ US$52.948.0% of flowCommon StockSEC:0001601712-25-000134:0
13,586 shares@ US$104.234837.8% of flowCommon StockSEC:0001225208-25-002270:0
13 shares@ US$65.290.1% of flowDividend Equivalent UnitSEC:0001601712-25-000076:0
635 shares@ US$65.016.3% of flowCommon StockSEC:0001601712-25-000013:0
15 shares@ US$64.980.1% of flowDividend Equivalent UnitSEC:0001601712-24-000374:0
827 shares@ US$49.885.9% of flowCommon StockSEC:0001601712-24-000323:0
23 shares@ US$45.890.2% of flowDividend Equivalent UnitSEC:0001601712-24-000292:0
2,207 sharesCommon StockSEC:0001127602-24-021033:0
25 of 62 declarations
